Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06023303 · ClinicalTrials.gov registry record · NA
Prospective Clinical Study to Assess Safety and to Collect Data on Radiofrequency Microneedling Device(s) For the Purpose of Evaluating Treatment on Skin
A NA study of Dermatologic Conditions, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT06023303 is a NA study of Dermatologic Conditions that has completed, run by Cynosure. The registered enrollment target is 8 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06023303, a NA study of Dermatologic Conditions, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the Radiofrequency microneedling devices (Potenza and Morpheus) used in this study is to collect clinical data for dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.
Conditions Studied
Interventions
- DEVICE Potenza
- DEVICE Morpheus
Study Locations (1)
Massachusetts
- Cynosure, Inc - Westford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-06-21 |
| Est. Completion | 2023-08-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06023303
The ClinicalTrials.gov registry entry for NCT06023303 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cynosure, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dermatologic Conditions appearing as the primary indexed condition, and to 2 interventions - of which Potenza is the first listed.
NCT06023303 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06023303 about?
NCT06023303 is a clinical study titled "Prospective Clinical Study to Assess Safety and to Collect Data on Radiofrequency Microneedling Device(s) For the Purpose of Evaluating Treatment on Skin". The goal of the Radiofrequency microneedling devices (Potenza and Morpheus) used in this study is to collect clinical data for dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.
What is the current status of trial NCT06023303?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2023-06-21. Estimated completion is 2023-08-10.
What conditions does trial NCT06023303 study?
This clinical trial studies the following conditions: Dermatologic Conditions.
What interventions are being tested in trial NCT06023303?
The interventions under investigation include: Potenza (DEVICE), Morpheus (DEVICE).
Who is sponsoring clinical trial NCT06023303?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06023303 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dermatologic Conditions
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.